New-onset diabetes and hypertension as complications of liver transplantation

N Algarem; A Sholkamy; M Alshazly; A Daoud

doi:10.1016/j.transproceed.2013.12.007

New-onset diabetes and hypertension as complications of liver transplantation

Transplant Proc. 2014 Apr;46(3):870-2. doi: 10.1016/j.transproceed.2013.12.007.

Authors

N Algarem¹, A Sholkamy¹, M Alshazly², A Daoud³

Affiliations

¹ Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
² Surgery Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
³ Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: [email protected].

PMID: 24767368
DOI: 10.1016/j.transproceed.2013.12.007

Abstract

Background: Among the many complications that can occur after liver transplantation are diabetes and hypertension. In this study, we evaluated the overall prevalence of and identified predictors for post-transplantation diabetes and hypertension.

Methods: This study was retrospective. We collected the data of the patients from the database in the liver transplant unit.

Results: Incidence of new-onset diabetes after transplantation (NODAT) was 25% and incidence of post-transplantation hypertension was 20%. No predictors were found for NODAT. Predictors of post-transplantation hypertension were body mass index and use of cyclosporine.

Conclusions: Diabetes and hypertension are common after liver transplantation. Predictors of post-transplantation hypertension are high body mass index and use of cyclosporine.

MeSH terms

Diabetes Mellitus / etiology*
Humans
Hypertension / etiology*
Liver Transplantation / adverse effects*
Retrospective Studies